Align Technology Stock Price and Value Analysis

Align Technology (NasdaqGS:ALGN) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: ALGN (NasdaqGS)
  • Current price: $155.17
  • Sector: Unknown
  • Industry: Unknown

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Align Technology to reach your target.

Target type

ALGN Free Cash Flow Trend

Free Cash Flow trendline for ALGN
Free Cash Flow trendline for Align Technology
CSV

Based on historical returns, we believe that Align Technology can grow its free cash at a rate of about 26%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a great rate!
  • This stock is available at a great discount!
  • This company is solid.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ALGN Numbers

ALGN Price
(Align Technology stock price per share)
$155.17
[?] ALGN Fair Price
(based on intrinsic value)
$272.49
[?] ALGN Safety Price (based on a variable margin of safety) $177.12
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 72% higher than other Unknown stocks
[?] PE Ratio versus Industry 453% higher than other Unknown stocks
[?] Cash Yield 1.85%
[?] Free Cash Flow Jitter 45%

Insider Activity Summary

No open-market insider buys or sells are recorded in the six months to 2026-11-22.

The six months before that had 0 buys and 1 sale.

Recent Insider Activity

Open-market buys and sells reported by Align Technology's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2026-02-18 Morici John (EVP, CHIEF FINANCIAL OFFICER) Sell 7,969 $189.31

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 4,109,362 shares shorted. With 66,383,297 shares available for purchase and an average trading volume over the past 10 trading days of 1,245,610, it would take at least 3.3 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 1097149 25.4
2009 1097149 63.4
2010 1097149 116
2011 1097149 113
2012 1097149 112
2013 1097149 163
2014 1097149 201
2015 1097149 205
2016 1097149 206
2017 1097149 366
2018 1097149 441
2019 1097149 609
2020 1097149 503
2021 1097149 948
2022 1097149 325
2023 1097149 551
2024 1097149 510
2025 1097149 375

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $7,593 million against net income of $6,084 million, or 1.25 times. Net income was negative in 1 of the 18 years, and those years are left out of the ratio.

In 2025, operating cash flow was 1.45 times net income, compared with 1.10 times for the earliest three years (2008 to 2010).

In 2025, capital expenditures were $102 million, 17.3% of operating cash flow of $593 million, which leaves an estimated $491 million after capex. Across the 18 years with reported capex, it averaged 27.2% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 80 39.7 14.3 0.50
2009 -31.3 74.2 7.2 n/a
2010 74.3 130 18 1.74
2011 66.7 130 30.4 1.96
2012 58.7 134 38.3 2.28
2013 64.3 186 19.4 2.89
2014 146 227 24.1 1.56
2015 144 238 53.5 1.65
2016 190 248 70.6 1.31
2017 231 439 196 1.90
2018 400 555 223 1.39
2019 443 747 150 1.69
2020 1,776 662 155 0.37
2021 772 1,173 401 1.52
2022 362 569 292 1.57
2023 445 786 178 1.77
2024 421 738 116 1.75
2025 410 593 102 1.45

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2015 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $4,536 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In 10 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $3,223 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, cash spent repurchasing shares was $466 million, 124.1% of estimated free cash flow of $375 million. That was more than the estimated free cash flow of the year.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2015 205 n/a 102 102 49.7%
2016 206 n/a 96.2 96.2 46.6%
2017 366 n/a 104 104 28.4%
2018 441 n/a 300 300 68.0%
2019 609 n/a 400 400 65.7%
2021 948 n/a 375 375 39.6%
2022 325 n/a 435 435 134.0%
2023 551 n/a 592 592 107.6%
2024 510 n/a 353 353 69.2%
2025 375 n/a 466 466 124.1%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $304 million in 2008 and $4,035 million in 2025, a compound annual growth rate of 16.4% over 17 years. The starting revenue was under 10% of the latest, so that rate comes from a small base and says little about recent growth.

Revenue rose 0.9% from 2024 to 2025.

Our estimated free cash flow was $375 million in 2025, 9.3% of revenue. In 2008 the estimated margin was 8.4%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 304 25.4 8.4%
2009 312 63.4 20.3%
2010 387 116 30.1%
2011 480 113 23.5%
2012 560 112 20.0%
2013 660 163 24.7%
2014 762 201 26.4%
2015 845 205 24.2%
2016 1,080 206 19.1%
2017 1,473 366 24.8%
2018 1,966 441 22.4%
2019 2,407 609 25.3%
2020 2,472 503 20.4%
2021 3,953 948 24.0%
2022 3,735 325 8.7%
2023 3,862 551 14.3%
2024 3,999 510 12.8%
2025 4,035 375 9.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $1,095 million against total liabilities of $2,185 million, or 50.1% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 35.0% of total assets in 2025, compared with 20.8% in 2010, an increase of 14.2 percentage points.

Stockholders equity was $4,049 million in 2025, compared with $378 million in 2009, a rise of 971.9%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 11.7% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 355 166 n/a 378
2010 477 295 99.2 378
2011 649 306 158 491
2012 756 306 175 581
2013 832 243 198 634
2014 988 200 235 753
2015 1,159 168 311 848
2016 1,396 389 397 999
2017 1,784 450 630 1,154
2018 2,052 637 800 1,253
2019 2,501 550 1,155 1,346
2020 4,830 961 1,596 3,234
2021 5,942 1,099 2,319 3,623
2022 5,948 942 2,347 3,601
2023 6,084 937 2,453 3,630
2024 6,215 1,044 2,363 3,852
2025 6,234 1,095 2,185 4,049

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $155.17, our model's value equals that price if free cash flow grows an average of 15.0 percent a year over the 10 projection years. Our model assumes 25.9 percent a year for this stock, so the price implies growth of 15.0 percent, which is below the 25.9 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $203 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $124.14 9.8%
Current price $155.17 15.0%
20 percent above the current price $186.20 18.8%
Our model (stored fair price) $272.49 25.9%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Align Technology is priced at $155.17, under its safe value estimate of $177.12 (fair value: $272.49).

Free cash flow was positive in all 18 fiscal years we have for Align Technology under its current SEC filer.

Free cash flow from the first three years of data averaged $68.4 million, and from the last three $479 million: a sharp rise.

Free cash flow is volatile from year to year, with a variability measure of 45%.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

We do not have a dividend yield for Align Technology.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1097149.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-21
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: ALGN annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in ALGN

Does Align Technology have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: ALGN

This example shows how we apply the Trendshare checklist to ALGN: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 155.17
    • Market cap: $11B
    • EPS: 6.86
  2. Step 2 — Valuation checks

    • P/E: 22.62
    • FCF yield: 1.9%
    • Date checked: Nov 21, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.